ChemPartner PharmaTech Co Ltd Net Asset Momentum
ChemPartner PharmaTech Co Ltd net asset momentum. ChemPartner PharmaTech Co Ltd (300149) recorded a net asset momentum of 5.0% as of December 2025, with net assets of CN¥1.30 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is ChemPartner PharmaTech Co Ltd's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of ChemPartner PharmaTech Co Ltd (2007–2025)
Net asset momentum of ChemPartner PharmaTech Co Ltd from 2007 to 2025. This chart tracks ChemPartner PharmaTech Co Ltd's year-over-year net asset growth across 19 annual reporting periods from 2007 to 2025. The most recent momentum reading is +5.0%, with net assets of CN¥1.30 Billion CNY as of December 2025. Check ChemPartner PharmaTech Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
ChemPartner PharmaTech Co Ltd Net Asset Momentum by Year (2007–2025)
ChemPartner PharmaTech Co Ltd net asset momentum by year from 2007 to 2025. The table below shows the complete annual net asset history for ChemPartner PharmaTech Co Ltd from 2007 to 2025, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 300149 market cap overview.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.30 Billion | CN¥2.03 Billion | CN¥732.59 Million | ▲ +5.0% |
| 2024 | CN¥1.24 Billion | CN¥2.00 Billion | CN¥757.75 Million | ▼ -15.3% |
| 2023 | CN¥1.46 Billion | CN¥2.43 Billion | CN¥973.44 Million | ▼ -38.8% |
| 2022 | CN¥2.39 Billion | CN¥3.82 Billion | CN¥1.44 Billion | ▲ +20.0% |
| 2021 | CN¥1.99 Billion | CN¥4.22 Billion | CN¥2.23 Billion | ▼ -18.9% |
| 2020 | CN¥2.45 Billion | CN¥4.12 Billion | CN¥1.67 Billion | ▲ +6.5% |
| 2019 | CN¥2.30 Billion | CN¥3.77 Billion | CN¥1.46 Billion | ▲ +4.5% |
| 2018 | CN¥2.20 Billion | CN¥3.35 Billion | CN¥1.14 Billion | ▲ +163.9% |
| 2017 | CN¥835.45 Million | CN¥1.04 Billion | CN¥207.73 Million | ▲ +8.5% |
| 2016 | CN¥769.93 Million | CN¥793.16 Million | CN¥23.23 Million | ▲ +6.4% |
| 2015 | CN¥723.81 Million | CN¥756.00 Million | CN¥32.19 Million | ▲ +3.9% |
| 2014 | CN¥696.53 Million | CN¥741.13 Million | CN¥44.60 Million | ▲ +3.9% |
| 2013 | CN¥670.29 Million | CN¥703.99 Million | CN¥33.70 Million | ▲ +4.6% |
| 2012 | CN¥640.90 Million | CN¥667.61 Million | CN¥26.72 Million | ▲ +4.8% |
| 2011 | CN¥611.46 Million | CN¥633.82 Million | CN¥22.37 Million | ▲ +7.0% |
| 2010 | CN¥571.30 Million | CN¥587.42 Million | CN¥16.12 Million | ▲ +464.2% |
| 2009 | CN¥101.26 Million | CN¥136.30 Million | CN¥35.04 Million | ▲ +73.5% |
| 2008 | CN¥58.36 Million | CN¥86.93 Million | CN¥28.57 Million | ▲ +140.6% |
| 2007 | CN¥24.25 Million | CN¥67.79 Million | CN¥43.53 Million | — |